risperidone has been researched along with Marijuana Abuse in 9 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Marijuana Abuse: Use of marijuana associated with abnormal psychological, social, and or occupational functioning.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine whether subjective well-being and craving for cannabis were different in patients with schizophrenia or related disorders treated with either olanzapine or risperidone." | 9.13 | Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. ( de Haan, L; Linszen, D; van Beveren, NJ; van den Brink, W; van der Helm, M; van Nimwegen, LJ, 2008) |
| " In the current study, the effect of clozapine (n = 27, mean dosage 350 mg), risperidone (n = 54, mean dosage 3." | 5.38 | Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. ( Beduin, AS; Bruggeman, R; Cahn, W; de Haan, L; Dekker, N; Kahn, RS; Krabbendam, L; Linszen, DH; Machielsen, M; Myin-Germeys, I; van Os, J; Wiersma, D, 2012) |
| "To examine whether subjective well-being and craving for cannabis were different in patients with schizophrenia or related disorders treated with either olanzapine or risperidone." | 5.13 | Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. ( de Haan, L; Linszen, D; van Beveren, NJ; van den Brink, W; van der Helm, M; van Nimwegen, LJ, 2008) |
| "Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations." | 2.50 | Cannabis and schizophrenia. ( Gillies, D; Kalakouti, E; Kyprianou, K; McLoughlin, BC; Pushpa-Rajah, JA; Rathbone, J; Variend, H, 2014) |
| " In the current study, the effect of clozapine (n = 27, mean dosage 350 mg), risperidone (n = 54, mean dosage 3." | 1.38 | Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. ( Beduin, AS; Bruggeman, R; Cahn, W; de Haan, L; Dekker, N; Kahn, RS; Krabbendam, L; Linszen, DH; Machielsen, M; Myin-Germeys, I; van Os, J; Wiersma, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Thurstone, C | 1 |
| Loh, R | 1 |
| Foreman, K | 1 |
| Thurstone, CA | 1 |
| Wolf, C | 1 |
| Machielsen, MWJ | 1 |
| Veltman, DJ | 2 |
| van den Brink, W | 3 |
| de Haan, L | 4 |
| Machielsen, MW | 1 |
| McLoughlin, BC | 1 |
| Pushpa-Rajah, JA | 1 |
| Gillies, D | 1 |
| Rathbone, J | 1 |
| Variend, H | 1 |
| Kalakouti, E | 1 |
| Kyprianou, K | 1 |
| van Nimwegen, LJ | 1 |
| van Beveren, NJ | 1 |
| van der Helm, M | 1 |
| Linszen, D | 1 |
| Sevy, S | 1 |
| Robinson, DG | 1 |
| Napolitano, B | 1 |
| Patel, RC | 1 |
| Gunduz-Bruce, H | 1 |
| Miller, R | 1 |
| McCormack, J | 1 |
| Lorell, BS | 1 |
| Kane, J | 1 |
| Machielsen, M | 1 |
| Beduin, AS | 1 |
| Dekker, N | 1 |
| Kahn, RS | 1 |
| Linszen, DH | 1 |
| van Os, J | 1 |
| Wiersma, D | 1 |
| Bruggeman, R | 1 |
| Cahn, W | 1 |
| Krabbendam, L | 1 |
| Myin-Germeys, I | 1 |
| Makkos, Z | 1 |
| Fejes, L | 1 |
| Inczédy-Farkas, G | 1 |
| Kassai-Farkas, A | 1 |
| Faludi, G | 1 |
| Lazáry, J | 1 |
| Kaplan, GB | 1 |
| McRoberts, RL | 1 |
| Smokler, HJ | 1 |
1 review available for risperidone and Marijuana Abuse
| Article | Year |
|---|---|
Cannabis and schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cannabinoids; Humans; Marijuana Abuse; Medical M | 2014 |
4 trials available for risperidone and Marijuana Abuse
| Article | Year |
|---|---|
Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
Topics: Antipsychotic Agents; Brain; Brain Mapping; Clozapine; Comorbidity; Craving; Cues; Humans; Magnetic | 2018 |
The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study.
Topics: Adolescent; Adult; Antipsychotic Agents; Attentional Bias; Brain Mapping; Clozapine; Craving; Humans | 2014 |
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Comorbidity; Disruptive, Impulse Control, | 2008 |
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Benzodiazepines; Diagnostic and Statistical M | 2010 |
4 other studies available for risperidone and Marijuana Abuse
| Article | Year |
|---|---|
Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis.
Topics: Adolescent; Adolescent, Hospitalized; Antipsychotic Agents; Aripiprazole; Humans; Marijuana Abuse; P | 2023 |
Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cannabis; Clozapine; Cohort Studies; Dopamine; Female; | 2012 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diben | 2011 |
Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder.
Topics: Alcoholism; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Baclofen; Bipolar Disord | 2004 |